Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Xeljanz (tofacitinib)

Indications: Ulcerative colitis

Call For Patient Input: May 22, 2018

Patient Input Closed: July 11, 2018

Velphoro (sucroferric oxyhydroxide )

Indications: Hyperphosphatemia, end-stage renal disease

Call For Patient Input: May 10, 2018

Patient Input Closed: June 29, 2018

Xarelto (rivaroxaban)

Indications: Prevention of stroke and cardiovascular events in coronary and peripheral artery disease.

Call For Patient Input: April 26, 2018

Patient Input Closed: June 15, 2018

TBC (crisaborole )

Indications: atopic dermatitis

Call For Patient Input: April 26, 2018

Patient Input Closed: June 15, 2018

Breo Ellipta (fluticasone furoate/vilanterol)

Indications: Asthma

Call For Patient Input: April 4, 2018

Patient Input Closed: May 24, 2018